Concepedia

Biju Mangatt

BM

4

Publications

253

Citations

4

H-Index

2014

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

South College

Biju Mangatt is an author at GlaxoSmithKline (United States) specializing in antibody engineering, medicine, and antibody biology.

Top concepts

Publications per year

2014–2022

4

Publications

4

Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i> -Rearranged Cancers

Alexander Drilon, Romel Somwar, Biju Mangatt et al. · Cancer Discovery · 2018 · 198 citations · Full text

Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS Methodologies

Graham L. Simpson, Sophie M. Bertrand, Alan D. Borthwick et al. · Journal of Medicinal Chemistry · 2019 · 28 citations · Full text

Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening

Xinrong Tian, Dominic Suarez, Douglas W. Thomson et al. · Journal of Medicinal Chemistry · 2022 · 17 citations · Full text

300 Preclinical pharmacologic characterization of GSK2849330, a monoclonal AccretaMab® antibody with optimized ADCC and CDC activity directed against HER3

N. Clarke, Christopher B. Hopson, Alfred Hahn et al. · European Journal of Cancer · 2014 · 10 citations

, , +10

Rows per page

1–4 of 4